199 related articles for article (PubMed ID: 1937786)
21. Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection.
Cazorla SI; Frank FM; Becker PD; Arnaiz M; Mirkin GA; Corral RS; Guzmán CA; Malchiodi EL
J Infect Dis; 2010 Jul; 202(1):136-44. PubMed ID: 20497050
[TBL] [Abstract][Full Text] [Related]
22. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).
Malchiodi EL; Chiaramonte MG; Taranto NJ; Zwirner NW; Margni RA
Clin Exp Immunol; 1994 Sep; 97(3):417-23. PubMed ID: 8082296
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W
J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740
[TBL] [Abstract][Full Text] [Related]
24. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
Saldaña A; Sousa OE
J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
[TBL] [Abstract][Full Text] [Related]
25. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite.
Giordanengo L; Guiñazú N; Stempin C; Fretes R; Cerbán F; Gea S
Eur J Immunol; 2002 Apr; 32(4):1003-11. PubMed ID: 11920566
[TBL] [Abstract][Full Text] [Related]
26. [Cysteine-dependent protease in Trypanosoma cruzi useful for the diagnosis of Chagas disease].
Alberti Amador E; Fachado Carvajales A; Montalvo AM; Izquierdo Pérez LA; Fonte Galindo L
Rev Cubana Med Trop; 1998; 50(1):75-81. PubMed ID: 9842273
[TBL] [Abstract][Full Text] [Related]
27. Identification and partial characterization of Trypanosoma cruzi antigens recognized by T cells and immune sera from patients with Chagas' disease.
Gazzinelli RT; Leme VM; Cancado JR; Gazzinelli G; Scharfstein J
Infect Immun; 1990 May; 58(5):1437-44. PubMed ID: 2108932
[TBL] [Abstract][Full Text] [Related]
28. Carbohydrate epitopes are responsible for antibody cross-reactivity in Trypanosoma cruzi-infected mice.
Xu BX; Powell MR
J Parasitol; 1991 Oct; 77(5):808-10. PubMed ID: 1717672
[TBL] [Abstract][Full Text] [Related]
29. Expression of a recombinant Fab antibody fragment against cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Kaplan D; Baldi C; Chiaramonte MG; Fernandez MM; Levin MJ; Malchiodi E; Baldi A
Biochem Biophys Res Commun; 1998 Dec; 253(1):53-8. PubMed ID: 9875219
[TBL] [Abstract][Full Text] [Related]
30. Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.
Cazorla SI; Frank FM; Becker PD; Corral RS; Guzmán CA; Malchiodi EL
Vaccine; 2008 Apr; 26(16):1999-2009. PubMed ID: 18342408
[TBL] [Abstract][Full Text] [Related]
31. Human Chagas' disease: evolution of the antibody response and recognition of antigens of Trypanosoma cruzi.
Araujo FG; Israelski DM; de Titto EH
Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():522-6. PubMed ID: 3151007
[No Abstract] [Full Text] [Related]
32. Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigen.
Paranhos-Bacalla GS; Santos MR; Cotrim PC; Rassi A; Jolivet M; Camargo ME; Da Silveira JF
Parasite Immunol; 1994 Mar; 16(3):165-9. PubMed ID: 8208589
[TBL] [Abstract][Full Text] [Related]
33. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients.
Fonseca SG; Moins-Teisserenc H; Clave E; Ianni B; Nunes VL; Mady C; Iwai LK; Sette A; Sidney J; Marin ML; Goldberg AC; Guilherme L; Charron D; Toubert A; Kalil J; Cunha-Neto E
Microbes Infect; 2005 Apr; 7(4):688-97. PubMed ID: 15848276
[TBL] [Abstract][Full Text] [Related]
34. Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice.
Guiñazú N; Pellegrini A; Giordanengo L; Aoki MP; Rivarola HW; Cano R; Rodrigues MM; Gea S
Microbes Infect; 2004 Nov; 6(14):1250-8. PubMed ID: 15555530
[TBL] [Abstract][Full Text] [Related]
35. Immunoparasitological studies of Trypanosoma cruzi low virulence clones from Panama: humoral immune responses and antigenic cross-reactions with Trypanosoma rangeli in experimentally infected mice.
Saldaña A; Sousa OE; Orn A
Scand J Immunol; 1995 Dec; 42(6):644-50. PubMed ID: 8552988
[TBL] [Abstract][Full Text] [Related]
36. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections.
Leguizamón MS; Campetella O; Russomando G; Almiron M; Guillen I; Ganzález Cappa SM; Frasch AC
J Infect Dis; 1994 Dec; 170(6):1570-4. PubMed ID: 7995998
[TBL] [Abstract][Full Text] [Related]
37. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
Lima AP; dos Reis FC; Serveau C; Lalmanach G; Juliano L; Ménard R; Vernet T; Thomas DY; Storer AC; Scharfstein J
Mol Biochem Parasitol; 2001 Apr; 114(1):41-52. PubMed ID: 11356512
[TBL] [Abstract][Full Text] [Related]
38. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
[TBL] [Abstract][Full Text] [Related]
39. Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting.
Dopico E; Del-Rei RP; Espinoza B; Ubillos I; Zanchin NIT; Sulleiro E; Moure Z; Celedon PAF; Souza WV; da Silva ED; Gomes YM; Santos FLN
BMC Infect Dis; 2019 Mar; 19(1):251. PubMed ID: 30871504
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
Caballero ZC; Sousa OE; Marques WP; Saez-Alquezar A; Umezawa ES
Clin Vaccine Immunol; 2007 Aug; 14(8):1045-9. PubMed ID: 17522327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
